# DESCRIPTION

## FIELD

- define field of invention

## BACKGROUND

- introduce canine idiopathic pulmonary fibrosis
- describe human idiopathic pulmonary fibrosis
- discuss genetic background of disease

## SUMMARY

- identify need for IPF diagnosis and treatment
- propose canine IPF as model for human disease
- describe method for detecting IPF/CIPF
- outline treatment options for IPF
- introduce breeding method for reducing CIPF propensity

## DETAILED DESCRIPTION

- define singular and plural references
- motivate genome-wide association study
- describe amplification reaction
- define polymerase chain reaction
- explain primer and primer pair
- define target or marker
- describe allele and its variations
- explain haplotype and linkage disequilibrium
- define amplification and template specificity
- describe template and background template
- explain detection methods
- define real-time PCR
- describe marker and its representations
- explain expression and its assessment
- define differential expression
- describe methods of assessing differential expression
- introduce method of comparing marker in sample to control samples
- describe prediction of cellular or physiological characteristic
- list sources of biological samples
- define subject or patient
- provide examples of subjects
- describe prediction of cellular or physiological characteristic
- describe assessing risk of disease outcome
- describe determining level of expression that signifies physiological or cellular characteristic
- introduce nucleic acid amplification methods
- describe PCR process
- describe real-time PCR analysis
- describe probe and primer design
- define sample or biological sample
- describe extraction of nucleic acids
- define nucleic acid or polynucleotide

### Example

- collect saliva samples
- extract DNA and perform whole genome sequencing
- process sequencing reads and impute missing data
- filter and quality control data
- perform principal component analysis and identify outliers
- estimate relatedness between samples
- conduct genome-wide association study
- correct for multiple testing and population structure
- annotate variants and perform gene-based association analysis
- compute GATES statistics and correct for multiple testing
- compare results with human IPF GWAS
- analyze allele frequencies
- present results
- introduce genetic risk factors for CIPF
- describe GWAS results
- discuss CPSF7 gene
- discuss SDHAF2 gene
- compare results with human IPF GWAS
- conclude identification of genetic variants
- introduce use of minor allele variant SNPs for IPF identification
- describe treatment options for IPF or CIPF
- list pharmaceutical compositions for treatment
- describe physical form of pharmaceutical compositions
- discuss pharmaceutical compositions as gas or aerosol
- describe solvates of pharmaceutical compositions
- define treatment of a condition
- discuss pharmaceutical carriers and formulations
- describe methods of administration

